BREAKTHROUGH FOR ME
by Geraint Jones
For years, ME has been treated with suspicion by doctors. Many believe that
for every genuine sufferer there is another who simply believes himself to be
ill. Experts cannot agree on whether the condition is a physical illness or a
psychological disorder which exists only in the victim's mind. One reason for
this scepticism is that, as yet, no one has been able to provide an accurate
diagnosis for ME, or myalgic encephalomyelitis, which is known to affect
150,000 people in Britain. There is no known cure and treatment is often based
on antidepressant drugs like Prozae, with limited success.
All this may be about to change. Dr Ian James, consultant and reader in
clinical pharmacology at London's Royal Free Hospital School of Medicine,
believes that he has found a way of diagnosing the chronic fatigue syndrome and
hopes to use it to develop a treatment programme. The breakthrough came after
months of research spearheaded by Dr James and Professor John Barbur of
London's City University. It centres round the discovery that the eyes of ME
sufferers respond to light and motion stimuli in an unusual way.
"Several doctors treating ME patients noticed that they showed an
abnormal pupil response", says Dr James. "When the pupil is subjected
to changes in light, or is required to alter focus from a close object to one
further away, it does so by constricting and dilating. ME patients' eyes do
this as well but there is an initial period of instability when the pupil
fluctuates in size".
Using a computerised "pupilometer", which precisely measures eye
responses, Dr James embarked on a detailed study of this phenomenon on ME
patients, using non-sufferers as a control. A variety of shapes were flashed on
to a screen and moved across it, while a computer precisely measured pupil
reflex to each of the 40 tests. Results confirmed that the pupil fluctuation
was peculiar to those participants who suffered from ME.
Dr James concluded that the abnormal pupil response is a result of some kind
of interference in the transfer of impulses from the brain to the eye. He
believes that ME is the result of a deficiency of a neuro-transmitter called
5HT, whose job it is to pass impulses through nerves to cells. The eyes of ME
sufferers treated with 5HT behave normally. "I do not yet know how the ME
virus causes abnormalities in 5HT transmission but it does inhibit its
function", says Dr James.
By administering drugs to stimulate levels of 5HT, together with treatment
aimed at fighting post-viral disease, Dr James believes that ME sufferers can
be cured. "I believe that ME is a problem of the brain, a
neuro-pharmacological disorder. The people I see are very motivated towards
getting better. The ME can mean they are bed-ridden for years, yet they look
quite well, so people have no sympathy. I believe that there is a physical
cause for chronic fatigue, but there undoubtedly is a strong link between ME
and the psychological make-up of a sufferer. Many sufferers are perfectionists
who take on a mammoth work-load. They cannot switch off. If they are laid low
by a virus, they do not recover from it properly, and that is where their
problems start. It may be that their psychological make-up renders them
vulnerable to the ME. But it is not the cause".
Dr James believes that there may be several different fatigue syndromes
hiding under the ME umbrella. Some patients suffer depression, others do not.
Some are permanently tired, others tire occasionally. Some recover after a few
months, others take years.
"There is no evidence of structural damage to the brain, so everyone is
capable of recovery from ME", he says. He stresses that there is much work
still to be done and needs more ME sufferers to volunteer to take part in his
research. Anyone interested should contact the Persistent Virus Disease
Research Foundation,
01494 674769.
|